The purpose of this paper is to review various factors of the control of cardiac contractility and of vascular tone that may be altered in heart failure and that are targets for pharmacotherapeutic interventions. This paper is divided into three main sections: pathophysiological aspects of heart failure, differences in the regulation of cardiac contraction and of vascular tone, and pharmacological principles in the management of heart failure
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Heart failure - either with reduced or preserved ejection fraction (HFrEF/HFpEF) - is a clinical syn...
Heart failure is a multi-factorial progressive disease in which eventually the contractile performan...
Abnormalities of cytosolic calcium handling and myocyte energetics appear to play an important role ...
AbstractCongestive heart failure is a common clinieal syndrome, with a relatively poor prognosis in ...
The rationale for the use of drugs and supportive therapy in the management of heart diseases (HDs) ...
Congestive heart failure is related to abnormal ventricular contraction and relaxation. Recent publi...
Chronic heart failure is a progressive and life-limiting syndrome that is caused by a failure of the...
Certain aspects of cardiac function as related to the normal and diseased heart are summarized. Topi...
To research the change in the physiological mechanism between the heart failure (HF) patient and hea...
Cardiac dysfunction precipitates changes in vascular function, blood volume, and neurohormonal statu...
Abstract Heart failure is one of the major problems related to heart diseases in the modern era. Mul...
Chapter 1 offers an introduction in which the place of vasodilator therapy in heart failure is descr...
The heart and blood vessels are constantly interfering with each other in a closed system. For a few...
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Heart failure - either with reduced or preserved ejection fraction (HFrEF/HFpEF) - is a clinical syn...
Heart failure is a multi-factorial progressive disease in which eventually the contractile performan...
Abnormalities of cytosolic calcium handling and myocyte energetics appear to play an important role ...
AbstractCongestive heart failure is a common clinieal syndrome, with a relatively poor prognosis in ...
The rationale for the use of drugs and supportive therapy in the management of heart diseases (HDs) ...
Congestive heart failure is related to abnormal ventricular contraction and relaxation. Recent publi...
Chronic heart failure is a progressive and life-limiting syndrome that is caused by a failure of the...
Certain aspects of cardiac function as related to the normal and diseased heart are summarized. Topi...
To research the change in the physiological mechanism between the heart failure (HF) patient and hea...
Cardiac dysfunction precipitates changes in vascular function, blood volume, and neurohormonal statu...
Abstract Heart failure is one of the major problems related to heart diseases in the modern era. Mul...
Chapter 1 offers an introduction in which the place of vasodilator therapy in heart failure is descr...
The heart and blood vessels are constantly interfering with each other in a closed system. For a few...
AbstractAdvances in the treatment of heart failure with angiotensin-converting enzyme inhibitors hav...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Heart failure - either with reduced or preserved ejection fraction (HFrEF/HFpEF) - is a clinical syn...